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Coupling of transient near 
infrared photonic with magnetic 
nanoparticle for potential 
dissipation-free biomedical 
application in brain
Vidya Sagar1, V. S. R. Atluri1, A. Tomitaka1, P. Shah2, A. Nagasetti2, S. Pilakka-Kanthikeel1, 
N. El-Hage1, A. McGoron2, Y. Takemura3 & M. Nair1
Combined treatment strategies based on magnetic nanoparticles (MNPs) with near infrared ray (NIR) 
biophotonic possess tremendous potential for non-invasive therapeutic approach. Nonetheless, 
investigations in this direction have been limited to peripheral body region and little is known about 
the potential biomedical application of this approach for brain. Here we report that transient NIR 
exposure is dissipation-free and has no adverse effect on the viability and plasticity of major brain 
cells in the presence or absence superparamagnetic nanoparticles. The 808 nm NIR laser module 
with thermocouple was employed for functional studies upon NIR exposure to brain cells. Magnetic 
nanoparticles were characterized using transmission electron microscopy (TEM), X-ray diffraction 
(XRD), dynamic laser scattering (DLS), and vibrating sample magnetometer (VSM). Brain cells viability 
and plasticity were analyzed using electric cell-substrate impedance sensing system, cytotoxicity 
evaluation, and confocal microscopy. When efficacious non-invasive photobiomodulation and neuro-
therapeutical targeting and monitoring to brain remain a formidable task, the discovery of this 
dissipation-free, transient NIR photonic approach for brain cells possesses remarkable potential to add 
new dimension.
Magnetic nanoparticles (MNPs) have been intensively investigated for various biomedical applications which 
includes therapeutic drugs targeting, gene delivery, bio-separation of biological entities, hyperthermia induced 
destruction of cells and tumors, magnetic resonance imaging (MRI), stem cell tracking, tissue repair, bio-sensing, 
etc.1–13. MNPs possess a distinct advantage over other nanocarriers because of their inherent superparamag-
netism which allows control over its magnetization and therefore its movement/speed can be regulated. By apply-
ing remote, non-invasive magnetic forces of required intensity at the desired site it is possible to achieve tissue/
cell-specific targeting with MNPs. Other characteristics of MNPs which make them popular are feasibility in 
production14 that they can be used as a contrast agent for MRI4,14, and their amphoterism in aqueous medium15,16. 
In aqueous solution, MNPs develop a positive or negative charge at the surface-water interface in a pH-dependent 
manner which allows ionic bonding of varieties of molecules at their surface17. Higher immobilization of mol-
ecules on MNPs can be achieved by coating or functionalization of MNPs with various surfactants4. Thus, the 
well-defined and rigid structures of MNPs serve as a solid binding platform for various ligands of diagnostic or 
therapeutical importance. MNPs can also be encapsulated in liposomes to create magnetoliposomes18. This can 
prevent MNPs bound drugs from direct exposure to phagocytic cells of reticuloendothelial system and other 
detrimental enzymatic activity in blood circulation and, in turn, physiological bioavailability of therapeutics can 
be significantly increased. Importantly, external control over the movement of MNPs exponentially improves the 
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ability of the nanocarrier to reach the target site by reducing its peripheral circulation time compared to other 
nanocarriers3. Moreover, the iron content in MNPs–in particular the magnetite and maghemite- can be readily 
metabolized by cellular regulation using the transferrin pathway. This makes MNPs easily degradable and able to 
pass in and out of cells across the plasma membrane19. Thus, MNPs within the permissible dose limit should have 
non-significant safety concerns and can be extremely suitable for in vivo applications20.
In the past decade, several studies have been carried out on the development of stimuli responsive materials 
or techniques to design stimuli-responsive nano-devices for biomedical applications. These devices can be sen-
sitive to a range of stimuli, which include change in pH, glutathione concentration or enzyme concentration, 
changes associated with the pathological situation, and extracorporeal physical stimuli via photo-, thermo- or 
ultrasound-targeting. These stimuli cause specific protonation, hydrolytic cleavage, molecular or supramolec-
ular conformational changes in the material to exert the desired effect21–23. Laser-initiated photo-targeting has 
shown tremendous potential for cancer therapy, gene delivery, imaging, and on-demand drug delivery24–27. In 
most cases phototargeting is achieved by hybridizing a light source with other existing techniques. As such light 
sensitive hydrogels28–30 and liposomes31 have been discovered in recent years. Some studies used light in the 
UV and visible spectral range for optoporation of macromolecules in cells32–34. However, light in the UV-visible 
range potentiates damage to the cellular organelles, DNA and proteins. Moreover, deeper penetration of light 
in the UV-visible wavelength into in vivo tissues or organs is not possible due to higher scattering and absorp-
tion. Recently, near infrared (NIR) region light in the wavelength range of 700–1000 nm has been experimented 
for several biological applications. This wavelength range is referred to as transparency “therapeutic window” 
because of deeper in vivo penetration and minimum absorption and scattering in compare to UV-VIS light35–39. 
Nonetheless, second (1100–1350 nm) and third (1600–1870 nm) NIR spectral window may be more superior40. 
Different energy levels of NIR light beam are applied from femtoseconds to several minutes as per the necessity 
of application19,26,30,37,40–42.
NIR phototargeting, in conjugation with MNPs, has largely been restricted for peripheral cancer therapy 
by photothermal effects where targeted irradiation is applied for more than 15 minutes19,42–44. Considering the 
sophistication and interdependence of brain cells networks in driving nuances of body physiology a damag-
ing thermal effect should be minimized or avoided while targeting brain. As such, transient or intermittent 
NIR exposure to brain cells can be more accommodating for their physiological ambience. A recent study sug-
gests MNPs-NIR assisted improved gene delivery with no cytotoxicity26. Similarly, a magnetic/NIR-responsive 
on-demand, targeted drug delivery and multicolor imaging system have been invented27. Again, applications of 
this unique (combined) approach have been limited to peripheral body regions. Almost all neurological disorders 
remain untreated, primarily due to lack of a technique that can deliver therapeutic devices for disease diagno-
sis and/or treatment across the impenetrable blood-brain barrier (BBB) as and when required. Several ongoing 
studies showing safe use of MNPs for imaging diagnosis, drug delivery, etc. in the brain region remain at the 
pre-clinical stage. An improvement by combining magnetic and NIR-responsive techniques may be beneficial 
in this regard. The application can range from brain cell specific gene delivery, imaging and on-demand drug 
targeting to magnetized photobiomodulation for treating various neuro-disorders. Nonetheless, physiological 
implications of combined MNP/NIR phototargeting on different brain cells need to be examined. As such, we 
studied the effect of NIR exposure on different brain cells with or without MNP treatment. Herein, for the first 
time, we report that short exposure of NIR light with a wavelength of 808 nm does not affect the viability and 
growth behavior of three major brain cells, namely, human primary astrocytes, the SKNMC neuronal cell line, 
and CHME microglia cell lines. Also, combined MNP/NIR phototargeting did not affect the spinal plasticity of 
SKNMC neuroepithelioma cells. Thus, we believe that this combined approach can be of safe for their potential in 
varieties of CNS related biomedical application.
Materials and Methods
Synthesis of magnetic nanoparticles. The co-precipitation method was used for synthesis of magnetic 
nanoparticles18. Briefly, 3 ml FeCl3 (0.487 g dissolved in 2 mol l−1 HCl) was thoroughly mixed in 10.33 ml H2O 
and subsequent drop-by-drop addition of 2 ml Na2SO3 (0.126 g in 2 ml of water) to this solution was stir-mixed 
within a minute. Gradually the reaction solution turns from yellow to red-light yellow. Now 80 ml of ammonium 
hydroxide solution (0.80 mol−1) is added with vigorous stirring which lead to black precipitation. The solution is 
kept under continuous stirring for additional 30 minutes. The resultant MNPs crystals are washed and suspended 
in H2O which measures a pH of 7.5. The stability of MNPs can be achieved by adjusting the pH to 3.0 and subse-
quent heating at 90 °C and 100 °C for 5 and 60 min, respectively. All process was performed at room temperature.
Characterization of magnetic nanoparticles. Structural conformation of synthesized MNPs was ver-
ified using Bruker GADDS/D8 X-ray diffraction system with Apex Smart CCD Detector and Mo direct-drive 
rotating anode (50 kV; 20 mA). Diffraction patterns were analyzed and indexed using ICDD PDF 2015 database 
and Match software. Further, to confirm the elemental composition of MNPs, energy dispersive spectroscopy 
(EDS) was conducted in scanning electron microscopy (JEOL JSM 5900LV) at 15 kV and working distance of 
10 mm.
The hydrodynamic radius and size distribution of MNPs were analyzed using dynamic laser scattering 
(DLS) (90 Plus particle size analyzer, Brookhaven Instruments, USA) at room temperature. Further, to exam-
ine the original crystal size, transmission electron microscopy (TEM) analysis was performed with the JEOL 
1010 Transmission Electron microscope operated at 100 kV. The magnetization curve of MNPs was measured 
using vibrating sample magnetometer (VSM-3, Toei Kogyo, Tokyo, Japan) equipped with an electromagnet 
(TEM-WFR7, Toei Kogyo, Tokyo, Japan) and a gaussmeter (Model 421, Lake Shore Cryotronics, Inc.). The meas-
urement was conducted at room temperature with a maximum field of 780 kA/m.
www.nature.com/scientificreports/
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The Agilent 8453 UV-Visible Spectrometer with Quartz-1 cm path length was used for evaluating absorbance 
of MNPs from 200 to 1000 nm wavelength.
Cell culture. SK-N-MCs, a neuroepithelioma cell line derived from a metastatic supra-orbital human brain 
tumor, were cultured in minimum essential medium (MEM). MEM was supplemented with 10% fetal bovine 
serum (FBS), 100 U/ml penicillin, and 100 mg/ml streptomycin (Gibco-BRL, Gaithersburg, MD). Cells were incu-
bated at 37 °C in a 5%CO2 incubator. Similarly, human primary astrocytes (HA) and CHME-5 human microglia 
cells were cultivated as per provider’s recommendations.
NIR Exposure. NIR exposure was performed with collimated NIR Laser Module source (RLDH808–1200-5, 
Roithner Laserthchnik Gmbh, Vienna, Austria) as described by Tang and McGoron45. 808 nm NIR with ~1.5 W/cm2 
power density was focused for 2 minutes on brain cells (human primary astrocytes, SKNMC neuronal cells, 
and CHME-5 glia cells) cultured in 96 well plates in the presence or absence of MNPs (50 μ g MNPs/ml). 
This fixed laser source has spot size of 5 mm which approximately covers central 80% cells of a well in 96 well 
culture plates. Cells in the periphery of a well are exposed due to potential beam-spread upon surface hitting 
of NIR during irradiation and as such whole well is illuminated (Supplementary Fig. 3). Cells were cultured in 
alternate wells so that potential cross-talk of NIR to a specific well was minimized for an adjacent well. Cells were 
pre-treated with MNPs 12 hrs before NIR targeting. Temperature of a specific well was measured using a thermo-
couple (0.22 mm diameter) for the entire 0–2 min of NIR exposure.
Cell viability assay. The MTT (Thiazolyl blue tetrazolium bromide) cell proliferation assay was performed 
as described previously17,18,46. Briefly, cells after NIR treatment were re-incubated at 37 °C for 3–6 hours (to imitate 
a real-time situation where cells will be under the natural condition post NIR treatment). Cells from different 
experimental groups were given a 200 μ l media change with 20 μ l MTT solution added and gently rocked in the 
dark at room temperature for 2–3 hrs. One volume of STOP solution containing 20% SDS in 50% dimethyl for-
mamide was added to the rocking cell suspension in MTT solution and further gently rocked in the dark at room 
temperature for 1–2 hrs. The cell suspension was centrifuged at 2000 rpm for 10 minutes and the supernatant was 
collected for the optical density determination of the solubilized formazan at 550 nm using Spectronic Genesys 
Bio10 spectrophotometer. The optical density of formazan in each treatment groups is directly proportional to 
the cell viability.
Cell growth resistance/impedance (Ω) measurement. Astrocytes growth resistance/impedance was 
measured with the help of the Electric cell-substrate impedance sensing instrument (model 1600RE, Applied 
Biophysics, USA) using 8W10E PET chips (Applied Biophysics), containing 8 cell culture wells47,48. Each well 
of the chip contains 10 working electrodes (250 μ m diameter) embedded in parallel on a gold connection pad 
and all wells share a common reference electrode. Astrocytes cultured with or without MNPs treatment were 
photo-targeted with NIR light and seeded in chip wells (5 × 104 cells/well). Both, the working and the reference 
electrodes were connected to a phase-sensitive lock-in amplifier through a 1 MΩ resistor before applying the 
AC signal. An electric potential of 1 V at 4 KHz was used for cell growth resistance measurements at 37 °C in a 
humidified incubator for 0–10 hrs.
Confocal microscopy and Characterization of neuro-spine density. Membrane staining of neuronal 
cells for confocal microscopy and measurement of spine density was performed according to the method adopted 
from Atluri et al.49. Cells were imaged using TCS SP2 Confocal Laser Scanning Microscope (Leica Microsystems, 
Germany) at 488 nm using 60X oil immersion objectives and 2.5X confocal electronic zoom.
Biostatistical analysis. Data in different figures are presented as mean ± standard error of three exper-
iments (n = 3). Student’s t-test was performed to compare means of two groups using GraphPad prism6 
(San Diego, Ca) and P values ≤ 0.05 were considered as significant.
Results and Discussion
Short-term MNPs-NIR exposure does not affect the temperature of cell culture ambience. We 
herein investigated the combined effect of MNPs and NIR treatment on growth dynamics of three major brain 
cells i.e. astrocytes, microglia and neuronal cells. MNPs were synthesized using the co-precipitation method 
which is regarded as one of the most efficient ways to prepare MNPs. In the co-precipitation method, either 
Na2SO3 or FeSO4 is used to reduce ferrous ion from FeCl3. While FeSO4 based reduction results in rod-shaped 
nanoparticles, the relatively gentle reduction ability of Na2SO3 in an aqueous solution produces round MNPs. 
The primary product of this reduction reaction is magnetite, which can be further acid-oxidized at 100 °C for 
maghemite as the more chemically stable end product. Nonetheless, both magnetite and maghemite has similar 
magnetic properties50. The crystalline structure and phase purity of synthesized nanoparticles were evaluated 
using x-ray diffraction spectroscopy which shows magnetite/maghemite specific diffraction peaks (220, 311, 400, 
511, and 440 planes; JCPDS 00-089-0691) (Fig. 1A). Further, Energy Dispersive X-Ray Spectorscopy (EDS) anal-
ysis confirmed FeO specific elemental composition. Observation of both FeL and FeK peaks for Fe3O4 in EDS 
is an expected outcome because many elements can be observed with more than one shell in a specific energy 
range (Supplementary Fig. 1). The polydispersity index of 0.19 in DLS suggests a very narrow size distribution of 
these particles. Nonetheless, average hydrodynamic size was estimated as 127 nm (Fig. 1B) which is higher than 
the TEM size of < 15 nm (Insert image in Fig. 1A). This size difference between TEM and DLS can be attributed 
to dried and aqueous solution of particles used during respective analysis. The hydrodynamic size of nanopar-
ticles in colloidal suspension is always greater than TEM due to adsorbed aqueous molecules. Water molecules 
(H-O-H) influence the surface charge (Fe-OH + H+ = Fe-OH2+/Fe-OH = Fe-O− + H+) which allows binding of 
www.nature.com/scientificreports/
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molecules (e.g. drugs, nucleic acid, etc.) to MNPs via ionic interaction for various biomedical applications. The 
magnetic hysteresis loops of these particles display high saturation magnetism at room temperature when meas-
ured between + 780 and − 780 Oe (Oersted). The magnetization curves displayed typical superparamagnetic 
behavior with no hysteresis and zero coercivity (Fig. 1C). The superparamagnetism can be utilized to manipulate 
MNPs movement for target-specific delivery by an external, non-invasive magnetic force and MNPs of this size 
possess several advantages for neurotargeting. Such as, it is possible to manipulate and target at the subcellular 
organelles levels51. Their higher surface to volume ratio increases loading efficiency of therapeutical agents on 
MNPs surfaces. More importantly, MNPs between 10–70 nm can readily penetrate capillary vessels17 and there-
fore it serves as a compatible therapeutical carrier that can transmigrate across the tightly junctioned brain micro-
vascular endothelial cells (BMECs) of BBB along the capillary lining throughout the cerebral microvasculature. 
Even with coatings of NIR responsive materials, such as hydrogels, liposomes, etc. on MNPs, the BBB transmigra-
tion ability of the nanoformulations is expected to be maintained. Magnetoliposomes up to 150 nm size have been 
reported to cross in vitro BBB by the application of 0.3 Tesla magnetic fields52. It is expected that the application 
of a magnetic field dissipate energy into magnetic particles resulting in a thermal impact on the targeted area. 
Nonetheless, the heating power of MNPs depends on the intensity and frequency of alternating magnetic field 
and MNPs size and geometry53–55. Particles within 30 nm size exert zero to minimum hyperthermia due to the 
magnetic field48. Also, many investigations have shown that MNP transmigration across the BBB using an exter-
nal magnetic force has no adverse effect on the integrity of tight junctions9-13,17,18,46,56,57.
NIR-based irradiation in the presence of MNPs was achieved using the collimated NIR laser delivery sys-
tem as shown in Fig. 2A. The system has been previously used to investigate the in vitro effect of the combined 
therapeutic modalities of chemotherapy and hyperthermia to cancer cell lines45. The NIR spectrum in the range 
of 800–1000 nm wavelength, itself, does not induce DNA damage and is non-toxic to tissues. However, heat 
may be released following exposure when a material that absorbs energy in the NIR region is present58,59. As 
such, NIR phototargeting in the presence of MNPs may lead to a photothermal effect which primarily depends 
on the duration and dose of NIR exposure and nanoparticle cluster density26,44,42,53. Studies suggest that in vivo 
cytotoxic effects due to hyperthermia are exerted only when NIR with higher power (> 3 Wm−2) is exposed for 
several minutes on a daily basis for several weeks in the presence of MNPs53. In fact, a study by Chu et al.42 shows 
that NIR exposure for less than 3 minutes on MNP treated cells does not induce any damage or adverse effect42. 
Short-term NIR exposure in conjugation with MNPs can be successfully applied for the gene delivery, imaging, 
and controlled drug delivery26,27. As a first step towards assessing the efficacy of this approach for the brain region, 
we evaluated the effect on temperature change of an in vitro cell culture system upon short-term NIR light expo-
sure (up to 2 minutes). The 808 nm NIR laser has been demonstrated to have superior CNS tissue penetration 
compared to light of other wavelengths such as 606 nm and 940 nm60. As such we selected this wavelength for 
our experiments. In clinical NIR based transcranial photobiomodulation ≤ 2 minute exposure of 808 nm NIR 
exposure has been shown efficacious in treating major depressive disorder61,62. Schematic in Fig. 2A shows the cell 
culture plate in the presence or absence of MNPs, which were homogenously exposed to 808 nm NIR with power 
Figure 1. Characterization of magnetite nanoparticles. (A) XRD spectrum of < 20 nm MNPs (in TEM 
insert image at top right hand side) showing magnetite-specific characteristics plane. (B) Dynamic laser 
scattering (DLS) measurement of hydrodynamic size distribution of MNPs shows an average colloidal size 
of nanoparticles is 127 nm. (C) Magnetic hysteresis loop of MNPs showing superparamagnetism i.e. zero 
coercivity at room temperature.
www.nature.com/scientificreports/
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~1.5 Wcm−2. Typical power intensities reported for photothermal treatment range from 1 to about 100 Wcm−2 63. 
Since no previous reports suggest combine use of MNPs and NIR for brain cells, a minimum recommended 
power density was selected considering higher physiological sensitivity of brain cells in compare to peripheral 
cells. To simulate the original cell culture condition, the temperature was maintained at 37 °C using the heated 
platform upon which the culture plates were placed during the NIR laser exposure and increase or decrease in 
temperature was measured using a thermocouple. As shown in Fig. 2B, NIR laser exposure on the cell culture 
system without MNPs showed a temperature rise of 0.46 ± 0.152 °C and that with MNPs showed an increase of 
0.83 ± 0.057 °C. MNPs absorption at 808 nm is near to bottom line i.e. extremely low (Supplementary Fig. 3). 
Nonetheless, laser beam energy absorbed by the components of cell-culture media may also add to the 0.46 °C 
temperature rise in the absence of MNPs. Thus, the net temperature rise upon NIR laser exposure in the presence 
of MNPs is only 0.37 ± 0.115 °C which is insignificant in terms of hyperthermia generation and can be fairly safe 
to use in an in vivo situation.
Short-term MNPs-NIR exposure does not affect the brain cell viability, growth behavior and 
plasticity. In order to assess the potential use for the brain region, we examined the nonspecific cytotoxicity 
of this novel MNPs-NIR during short-time (808 nm for 2 minute) treatment to three major brain cells, namely, 
Human primary astrocytes, SKNMC human neuroepithelioma cells, and CHME-5 human microglia cells. The 
results of quantitative cell cytotoxicity determined by the MTT cell proliferation assay showed that MNPs-NIR 
exposure was not toxic to any of the brain cell types used in this study (Fig. 3). Similar to our previous report17, 
Figure 2. Temperature profiling during NIR exposure. (A) Schematic of 808 nm NIR laser module: NIR 
source is fixed to a holder and connected to an external power supply. Beneath the NIR source is a heated 
stage insert to keep the cell-culture system at original culture of 37 °C. Temperature of cell culture system 
exposed to NIR with or without MNPs is measured with the help of a thermocouple wire. (B) Temperature 
profile of different experimental group: Cell culture with or without MNPs were exposed with ~1.5 Wcm−2 
NIR for 2 minutes and temperature were recorded via placing thermocouple at the bottom of well throughout 
the exposure period. Effect of NIR or MNPs-NIR on temperature of cell culture ambience of individual well 
was obtained by temperature difference at the beginning (0 second) and end (120 seconds) of exposure. NIR 
exposure on cell culture system without MNPs showed a temperature rise of 0.46 ± 0.152 °C and that of with 
MNPs showed an increase of 0.83 ± 0.057 °C (* P < 0.0177).
Figure 3. Percent cell viability of three major brain cells, namely, Human primary astrocytes, SKNMC 
human neuroepithelioma cells, and CHME-5 human microglia cell lines were obtained using MTT 
cytotoxicity assay. None of the treatment affected the viability of either of cell lines. Percent cell viability in the 
case of NIR-alone experiment was 98.45 ± 7.05, 101.58 ± 0.36, and 96.90 ± 4.85 for CHME-5 human microglia 
cell lines, Human primary astrocytes and SKNMC human neuroepithelioma cells and that for MNPs-NIR 
treatment was 96.00 ± 6.25, 104.58 ± 8.40, and 96.35 ± 3.64.
www.nature.com/scientificreports/
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MNPs alone did not deter the cell viability of Human primary astrocytes, SKNMC human neuroepithelioma cells 
or CHME-5 human microglia cells. NIR light with 800–100 nm wavelength can be transmitted across tissue with-
out inducing any damage to cellular macromolecules or organelles. As such, similar to MNPs-alone treatment, 
cell viability is expected to remains unaltered upon exposure of NIR-alone. Percent cell viability in the case of 
NIR-alone experiment was 98.45 ± 7.05, 101.58 ± 0.36, and 96.90 ± 4.85 for CHME-5 human microglia cells, 
Human primary astrocytes and SKNMC human neuroepithelioma cells, respectively. Similar to this result, it has 
been shown previously that 808 nm irradiation on Eca-109 cells for 20 minutes did not change their viability48. 
Shen et al.19 also showed the same for the A549 cells which were exposed to a 5 Wcm−2 808 nm NIR laser in the 
presence or absence of individually dispersed MNPs for 3 minutes19. As shown in Fig. 3, percent cell viability in 
the case of MNP-NIR treatment was 96.00 ± 6.25, 104.58 ± 8.40, and 96.35 ± 3.64 for CHME-5 human microglia 
cells, Human primary astrocytes and SKNMC human neuroepithelioma cells, respectively. The unaffected cell 
viability either during NIR-alone or MNPs-NIR exposure (Fig. 3) coincides with the insignificant temperature 
rise of the culture system (Fig. 2b). In fact, studies pertaining to the oncolytic effect of MNP-NIR exposure report 
that the cytotoxic effect is induced when the local temperature rise is greater than 42 °C 4,28. The “no-effect” exhi-
bition of cell viability in this study may also be because of the low light absorption by the natural endogenous 
cytochromes of cells upon short-term exposure, which may cause minimal temperature elevation accounting to 
the high cell survivability19. The unaffected percent cell viability potentiates the safe use of short-term MNP-NIR 
exposure for biomedical applications in the brain region.
While the MTT cell proliferation assay provides a general sense of cytotoxicity at a final time point after 
specific duration of treatment, analyzing the continuous growth behavior of cells over time may reveal kinetic 
effects of toxicity23,24. As such, astrocytes growth resistance/impedance was measured for 10 hours post-treatment 
using the electric cell-substrate impedance sensing method. This method measures the resistance (Ω ) produced 
by growing cell monolayers over the electrodes and can detect changes in resistance to AC current flow that 
may occur with changes in the cell layer47,48. Primarily, growth resistance of each treatment group is compared 
with resistance of blank well containing culture media to obtain blank-normalized resistance value. As shown 
in Fig. 4, growth-resistance kinetics of astrocytes with all kinds of treatments showed a steady upward slope. 
The end point blank-normalized resistance (Δ Ω ) value after 10 hrs of culture was 1.63, 1.49, 1.26, and 1.50 for 
NIR-alone treatment, MNPs-alone treatment,MNPs-NIR and untreated control exposure, respectively. Thus, the 
cell growth-resistances values were in the same range, which suggests a similar growth behavior of attached cells 
across all groups. The presence of MNPs on the electrode surface of the culture chip may result in a slower cellular 
attachment process; however, in a real in vivo scenario the effect on the cellular attachment process due to MNPs 
may be inconsequential. Moreover, the intrinsic AC properties of MNPs may also interfere with the AC current 
flow of the culture chip electrodes and subsequently may obstruct the cell growth-resistance behavior via the 
resistance measurement.These factors may have resulted in a relatively slower kinetic slope in MNPs-only and 
MNPs-NIR treated cells than the NIR-only and untreated control groups. A little up or down slope of the growth 
kinetics among groups is expected during the early hour due to variations in the cell attachment rate which can be 
influenced by many other factors such as initial cell density, cellular transitory metabolic slowdown due to treat-
ment effects, etc.47,48. Thus, a longer monitoring of cell growth-behavent, impedance sensing method may reflect 
a healthy cellular status and factors such as cell attachment and metabolic pause can be nullified. Nonetheless, the 
astrocytes growth-resistance pattern obtained for the initial 10 hrs is in accordance with the MTT assay (Fig. 3) 
suggesting no harmful effect of short-term MNPs-NIR exposure on cell health.
Long term effect of MNPs-NIR treatment on dendrite and spine morphology (synaptic plasticity) of SKNMC 
cells was monitored. Spine morphology plays an important role in maximizing the effectiveness of the synaptic 
transmission in brain and to the periphery17,49. Treated or untreated cells were allowed to grow on cover slip 
Figure 4. Cell growth behavior measurements for human primary astrocytes over 10 hours of culture: 
Growth-resistance (Ω) kinetics of astrocytes with all kinds of treatments showed a steady upward slope. 
The end point blank-normalized resistance (∆ Ω ) values were 1.63, 1.49, 1.26, and 1.50 for NIR-alone treatment, 
MNPs-alone treatment, MNPs-NIR, and untreated control exposure, respectively. Thus, the cell growth-
resistances patterns were in the same range which suggests a similar growth behavior of attached cells across all 
groups.
www.nature.com/scientificreports/
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for more than 72 hours such that homogenous elongation of dendritic and spinal projections can take place. 
Subsequently, cells were PBS-fixed and stained using the green-fluorescent membrane tracer 1, 1′ -Dioctadecyl-3, 
3,3′ ,3′ -tetramethylindocarbocyanine perchlorate. This lipophilic dye uniformly labels lipid contents of plasma 
Figure 5. Confocal microscopy to evaluate the dendrite and spine morphology (synaptic plasticity) of SKNMC 
cells after 72 hours of NIR treatment in the absence (C) or presence (D) of MNPs in compare to control (A,B): 
Healthy dendritic and spine morphology of SKNMC cells is evident for all treatments. This suggests NIR 
phototargeting did not alter the neuronal synaptic plasticity and thus, similar to short-term effect (Figs 3 and 4), 
long term effect of MNPs-NIR phototargeting potentiate towards the safe use of this novel approach.
Figure 6. Spinal density (No. of spines/μm dendritic length) of SK-N-MC: spine density remains 
unchanged in all treatments (Untreated Control: 0.77 ± 0.20 per μm2, MNPs: of 0.76 ± 0.14 per μm2, NIR: 
0.76 ± 0.13 per μm2, and MNP + NIR: 0.77 ± 0.17 per μm2) which show coupling of transient near infrared 
photonic with magnetic nanoparticle have no adverse effect on brain cell growth and behaviors. 
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membrane via lateral diffusion. The stained cells on slides were now microscoped for confocal imaging. The 60X 
immersion objectives lens at 488 nm illusion and 2.5x electronic zoom could give us the required magnification 
to visualize dendritic spine of individual cells. Spine density were quantified using obtained confocal images 
using a well-established protocol17,46,49 where ImageJ software is used to measure defined length of single cells and 
no. of spines present within that length is counted (spine density = number of spines/dendritic or cell length). 
As shown from confocal microscopy in Figs 5 and 6, healthy dendritic and spine morphology of SKNMC cells 
is evident for all treatments. NIR treated cells with or without MNPs showed a spinal density of 0.76 ± 0.13 and 
0.77 ± 0.17 per μ m2, respectively, whereas the same in untreated cells were approximately 0.77 ± 0.20 per μ m2 
(Fig. 6). Cells treated with MNPs only showed a spinal density of 0.76 ± 0.14 per μ m2(Fig. 6). We have shown ear-
lier, similar to this case (Fig. 5B), that MNPs alone did not affect the dendritic and spinal elongation17,46. Similarly, 
NIR-alone (Fig. 5C) and MNPs-NIR (Fig. 5D) treated cells showed dendritic and spinal morphology comparable 
to that of untreated controls (Fig. 5A). Thus, healthy synaptic plasticity was observed in all experimental groups. 
This result further substantiates the above observations that short-term MNPs-NIR exposures do not affect brain 
cell growth and behaviors and, as such, this novel, combined approach may be used for biomedical applications 
in brain regions.
Prospective. We demonstrated that transient NIR irradiation in presence of MNPs is dissipation free and safe 
for brain cells. Our results suggest that MNPs-NIR phototargeting does not have adverse effect on the viability, 
growth behavior and plasticity of brain cells. Thus, selected power density of ~1.5 W/cm2 and 2 minute time win-
dow for 808 nm NIR exposure in this report will open a referral point to explore higher power density laser for 
brain cells. This opens up a regime that can provide an exceptional opportunity for the safe use of this novel com-
binatorial approach for various biomedical innovations. Such as, transitory optoelectronic excitation-mediated 
molecular vibrations on MNPs surfaces, even for short NIR laser exposure, may change the charge distribution 
of MNPs surfaces and subsequently the ionic interaction of drugs can be broken. Thus controlled, on-demand 
drug release may be achieved. Discovery of NIR-sensitive materials such as hydrogels and liposomes may further 
advance the applicability of this approach where drugs bound MNPs can be encapsulated in liposomes or hydro-
gel layers. Brain targeting requires a faster reach of drug carriers with no or little exposure to RES for maximum 
bioavailability. External control over MNPs movement can be highly applicable for this purpose. Encapsulation 
can prevent drugs from digestion by direct reticuloendothelial system (RES) exposure and enzymztic activity 
of the peripheral circulation (blood), can remarkably improve the total drug loading capacity of the carrier by 
loading drugs on MNPs and encapsulating materials as well, and can enhance the drugs stability and prevent 
leaching in the blood circulation. Also, drug dissemination in healthy tissues can be prevented with maximized 
target bioavailability. A recent study by Tedford et al.60 showed that transcranial and intraparenchymal exposure 
of 808 nm NIR laser can successfully penetrate 40 mm deep into the scalp, human skull and meninges. As such, 
short-term MNPs-NIR (with or without coating of NIR sensitive materials) phototargeting may be a new inno-
vation for controlled, on-demand drug delivery in brain (Fig. 7) and for photobiomodulation to treat different 
psychological disorders. Moreover, while MNPs alone are used for MRI imaging; a “MNP-NIR sensitive fluores-
cent materials::core-shell” template can be an excellent use for multi-color imaging modalities. The NIR sensitive 
Figure 7. Proposed mechanism for efficacious targeting, delivery, release, and monitoring of therapeutics 
to brain using transient NIR photonics with MNPs for noninvasive brain targeting: An in silico-controlled, 
non-invasive magnetic force will drive MNPs across BBB and simultaneously NIR phototargeting can 
cause release of associated drugs (transitory optoelectronic excitation-mediated molecular vibrations on 
MNPs surfaces, even for short NIR laser exposure, change the charge distribution of MNPs surfaces and 
subsequently the ionic interaction of drugs can be broken with subsequent drug release). Also, while MNPs 
alone are used for MRI imaging; a “MNP-NIR sensitive fluorescent materials::core-shell” template can be an 
excellent use for multi-color imaging modalities. Combining fluorescent liposomes, hydrogels, carbon dots, 
or matrix of upconversion materials such as Erbium, Thulium, etc., can be used for this purpose because these 
materials can emit different color fluorescent lights depending on NIR wavelength.
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fluorescent materials may be liposomes, hydrogels, fluorescent carbon dots, or matrix of upconversion materials 
such as Erbium, Thulium, etc., which can emit different color fluorescent lights depending on NIR wavelength64. 
Nonetheless, sufficient research is required to establish permissible limits of different MNPs-NIR combination 
that have non-significant safety concerns before practical application on a real scenario.
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